Pharmageddon:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Berkeley
University of California Press
c2012
|
Schlagworte: | |
Online-Zugang: | FAW01 FAW02 Volltext |
Beschreibung: | Includes bibliographical references and index They used to call it medicine -- Medicine and the marketeers -- Follow the evidence -- Doctoring the data -- Trussed in guidelines -- The mismeasurement of medicine -- The eclipse of care -- Pharmageddon "This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system"--Provided by publisher |
Beschreibung: | 1 Online-Ressource (xii, 302 p.) |
ISBN: | 0520951816 1283369745 9780520951815 9781283369749 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV043056233 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 151126s2012 |||| o||u| ||||||eng d | ||
020 | |a 0520951816 |c electronic bk. |9 0-520-95181-6 | ||
020 | |a 1283369745 |9 1-283-36974-5 | ||
020 | |a 9780520951815 |c electronic bk. |9 978-0-520-95181-5 | ||
020 | |a 9781283369749 |9 978-1-283-36974-9 | ||
035 | |a (OCoLC)774290524 | ||
035 | |a (DE-599)BVBBV043056233 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-1046 |a DE-1047 | ||
082 | 0 | |a 338.4/76153 |2 23 | |
100 | 1 | |a Healy, David |e Verfasser |4 aut | |
245 | 1 | 0 | |a Pharmageddon |c David Healy |
264 | 1 | |a Berkeley |b University of California Press |c c2012 | |
300 | |a 1 Online-Ressource (xii, 302 p.) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
500 | |a They used to call it medicine -- Medicine and the marketeers -- Follow the evidence -- Doctoring the data -- Trussed in guidelines -- The mismeasurement of medicine -- The eclipse of care -- Pharmageddon | ||
500 | |a "This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system"--Provided by publisher | ||
650 | 7 | |a BUSINESS & ECONOMICS / Industries / Service |2 bisacsh | |
650 | 7 | |a MEDICAL / Health Care Delivery |2 bisacsh | |
650 | 7 | |a Medicine |2 fast | |
650 | 7 | |a Pharmacology |2 fast | |
650 | 4 | |a Drug Industry | |
650 | 4 | |a Drug Utilization | |
650 | 4 | |a Business | |
650 | 4 | |a Industrie | |
650 | 4 | |a Medizin | |
650 | 4 | |a Wirtschaft | |
650 | 4 | |a Pharmacology | |
650 | 4 | |a Medicine | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-520-27098-3 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-520-27098-5 |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=413318 |x Aggregator |3 Volltext |
912 | |a ZDB-4-EBA | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-028480425 | ||
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=413318 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=413318 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1804175428033708032 |
---|---|
any_adam_object | |
author | Healy, David |
author_facet | Healy, David |
author_role | aut |
author_sort | Healy, David |
author_variant | d h dh |
building | Verbundindex |
bvnumber | BV043056233 |
collection | ZDB-4-EBA |
ctrlnum | (OCoLC)774290524 (DE-599)BVBBV043056233 |
dewey-full | 338.4/76153 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 338 - Production |
dewey-raw | 338.4/76153 |
dewey-search | 338.4/76153 |
dewey-sort | 3338.4 576153 |
dewey-tens | 330 - Economics |
discipline | Wirtschaftswissenschaften |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03264nmm a2200553zc 4500</leader><controlfield tag="001">BV043056233</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0520951816</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-520-95181-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283369745</subfield><subfield code="9">1-283-36974-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780520951815</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-520-95181-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283369749</subfield><subfield code="9">978-1-283-36974-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)774290524</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043056233</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76153</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Healy, David</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmageddon</subfield><subfield code="c">David Healy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berkeley</subfield><subfield code="b">University of California Press</subfield><subfield code="c">c2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xii, 302 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">They used to call it medicine -- Medicine and the marketeers -- Follow the evidence -- Doctoring the data -- Trussed in guidelines -- The mismeasurement of medicine -- The eclipse of care -- Pharmageddon</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system"--Provided by publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Industries / Service</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Health Care Delivery</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Utilization</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Business</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-520-27098-3</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-520-27098-5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=413318</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028480425</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=413318</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=413318</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV043056233 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:16:07Z |
institution | BVB |
isbn | 0520951816 1283369745 9780520951815 9781283369749 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028480425 |
oclc_num | 774290524 |
open_access_boolean | |
owner | DE-1046 DE-1047 |
owner_facet | DE-1046 DE-1047 |
physical | 1 Online-Ressource (xii, 302 p.) |
psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | University of California Press |
record_format | marc |
spelling | Healy, David Verfasser aut Pharmageddon David Healy Berkeley University of California Press c2012 1 Online-Ressource (xii, 302 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index They used to call it medicine -- Medicine and the marketeers -- Follow the evidence -- Doctoring the data -- Trussed in guidelines -- The mismeasurement of medicine -- The eclipse of care -- Pharmageddon "This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system"--Provided by publisher BUSINESS & ECONOMICS / Industries / Service bisacsh MEDICAL / Health Care Delivery bisacsh Medicine fast Pharmacology fast Drug Industry Drug Utilization Business Industrie Medizin Wirtschaft Pharmacology Medicine Erscheint auch als Druck-Ausgabe, Hardcover 0-520-27098-3 Erscheint auch als Druck-Ausgabe, Hardcover 978-0-520-27098-5 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=413318 Aggregator Volltext |
spellingShingle | Healy, David Pharmageddon BUSINESS & ECONOMICS / Industries / Service bisacsh MEDICAL / Health Care Delivery bisacsh Medicine fast Pharmacology fast Drug Industry Drug Utilization Business Industrie Medizin Wirtschaft Pharmacology Medicine |
title | Pharmageddon |
title_auth | Pharmageddon |
title_exact_search | Pharmageddon |
title_full | Pharmageddon David Healy |
title_fullStr | Pharmageddon David Healy |
title_full_unstemmed | Pharmageddon David Healy |
title_short | Pharmageddon |
title_sort | pharmageddon |
topic | BUSINESS & ECONOMICS / Industries / Service bisacsh MEDICAL / Health Care Delivery bisacsh Medicine fast Pharmacology fast Drug Industry Drug Utilization Business Industrie Medizin Wirtschaft Pharmacology Medicine |
topic_facet | BUSINESS & ECONOMICS / Industries / Service MEDICAL / Health Care Delivery Medicine Pharmacology Drug Industry Drug Utilization Business Industrie Medizin Wirtschaft |
url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=413318 |
work_keys_str_mv | AT healydavid pharmageddon |